ARTICLE | Company News
ArQule and SmithKline in drug discovery
November 28, 2000 8:00 AM UTC
ARQL will use its Parallel Track drug discovery technology to optimize two compounds for SmithKline Beecham (SBH; LSE:SB). One compound is from SB, and the other comes from ARQL's Compass Array librar...